Cyclin-dependent kinase inhibitor 2A (p16) and MCM7 were significantly upregulated in one of the tumour subsets, indicating that this subset (Gr2) could be characterised by E2F-regulated transcription. The gene discussed is CDKN2A; the disease is neoplasm.